Dr. Oakley studies the process by which cells, good or bad, are damaged by chemotherapy and he looks for ways to protect the healthy cells.
Dr. Oakley hopes to do this by targeting a protein called Replication Protein A (RPA).
|Greg Oakley, Ph.D., left, and Jason Glanzer, Ph.D. (Peggy Cain, College of Dentistry)|
Dr. Oakley, who has degrees in toxicology and pharmacy, came to the College of Dentistry in 2006 from the University of Cincinnati Medical Center where he first studied RPA in 1996.
His research crystallized last year when his research associate, Dr. Jason Glanzer's young daughter, five-year-old Abby Glanzer, developed a brain tumor. Abby was featured in the "Burger King Help Beat Cancer for Kids" campaign this year. She is now in remission.
"It brought the research home and gave it special meaning," Dr. Oakley said.